Suggestions for Streamlining and Optimizing Clinical End‐Point Bioequivalence Studies for <scp>US</scp> Abbreviated New Drug Application Submissions

20182 citationsJournal Article

Authors

The authors declared no competing interests for this work.

Published in: Clinical Pharmacology & Therapeutics

Volume 105, Issue 2, pp. 310-312

Field-Weighted Citation Impact: 0.24